Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 8,224,508 $ 2,108,544
Due from related parties 300,000
Prepaid expenses and other current assets 2,976,583 1,606,414
Total Current Assets 11,201,091 4,014,958
Intangible assets, net 1,948,913 2,047,818
In-process research and development 12,575,780 12,569,793
Goodwill 36,987,886 36,900,801
Total Assets 62,713,670 55,533,370
Current Liabilities:    
Accounts payable 586,611 8,529,259
Accounts payable - related parties 215,495
Accrued expenses 1,964,580 4,110,916
Accrued expenses - related parties 18,370 454,951
Loans payable - current portion 1,828,079 968,446
Loans payable - related parties 81,277 513,082
Convertible notes payable 1,916,195
Convertible notes payable - related parties 270,000
Derivative liabilities 15,220,367 4,442,970
Total Current Liabilities 19,699,284 21,421,314
Accrued issuable equity 43,095
Loans payable - non current portion 48,165 113,763
Deferred tax liability 3,643,526 3,668,329
Total Liabilities 23,390,975 25,246,501
Commitments and contingencies (Note 12)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; (see designations and shares authorized for Series A, Class C and Class K preferred stock)
Class C Preferred Stock; 1 share authorized, issued and outstanding at December 31, 2021 and 2020
Class K Preferred Stock; 1 share authorized, issued and outstanding at December 31, 2021 and 2020
Common stock, $0.0001 par value; 100,000,000 shares authorized; 34,035,925 and 26,171,225 shares issued and outstanding at December 31, 2021 and 2020, respectively 3,404 2,617
Additional paid-in capital 107,184,137 78,005,004
Accumulated other comprehensive income 817,440 636,886
Accumulated deficit (68,682,286) (48,357,638)
Total Stockholders’ Equity 39,322,695 30,286,869
Total Liabilities and Stockholders’ Equity $ 62,713,670 $ 55,533,370